BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Bay Area’s Intuitive Surgical Buys NC Facility Very Close to Rival TransEnterix

  The new acquisition joins a smaller facility Intuitive has in the region at N.C. State University’s Centennial Campus.

  October 19, 2017

   · 

  1 min read
• 

  FDA

  Novartis Has Set a Tricky Precedent in Gene Therapy

  A look at how the gene therapy approvals may end up confusing payers, lawmakers, and the general public at a time when the industry desperately needs clarity.

  October 19, 2017

   · 

  5 min read

   · 

  Karl Thiel
• 

  Drug Development

  DURECT Stock Plunges as Pain Med Fails Phase III

  DURECT’s Posimir (SABER - Bupivacaine) for post-surgical pain failed its Phase III clinical trial.

  October 19, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  FDA

  Eli Lilly Looks Over Its Shoulder After Novo Nordisk Wins FDA Panel Backing for Diabetes Drug

  An advisory panel with the FDA gave a near unanimous support to Novo Nordisk’s diabetes drug semaglutide, a long-acting GLP-1 analogue.

  October 19, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Abzena and UGA Biopharma Partner to Develop a Cell Line Expressing a Biosimilar Therapeutic for Multiple Sclerosis

  The partnership centered around the development of an NS0 (murine myeloma) manufacturing cell line, expressing a high quality, fully biosimilar antibody therapeutic.

  October 19, 2017

   · 

  4 min read
• Business

  Orexo Interim Report Q3 2017

  Financial overview Q3 2017 Total net revenues SEK 166.2M Zubsolv U.S. net revenue SEK 121.1M.

  October 19, 2017

   · 

  5 min read
• Business

  Quotient Clinical Signs Agreement With Nuformix to Evaluate Cocrystal Formulations Using Translational Pharmaceutics

  Under the deal, Quotient will use its Translational Pharmaceutics platform to develop a formulated oral NXP001 cocrystal product and validate its performance in healthy subjects.

  October 19, 2017

   · 

  2 min read
• Business

  Danaher Reports Third Quarter 2017 Results

  Danaher today announced results for the third quarter of 2017.

  October 19, 2017

   · 

  29 min read
• Policy

  Prometic Receives Priority Review Status From Health Canada for Plasminogen (Ryplazim)

  Prometic today announced that Health Canada has granted priority review status for the NDS the company plans to file for its plasminogen replacement therapy (RyplazimTM) for the treatment of patients with plasminogen deficiency.

  October 19, 2017

   · 

  4 min read
• Business

  Teleflex Announces Third Quarter 2017 Earnings Conference Call Information

  Teleflex announced today that financial results for the third quarter 2017 will be released before market open on Thursday, November 2, 2017.

  October 19, 2017

   · 

  1 min read